Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-08-04FDA Approved: FENOFIBRATE — Supplemental Application (Bostal LLC)
Supplemental approval for fenofibrate from Bostal LLC.
-
EMA approval · 2026-03-13EMA Authorised: Vazkepa (Icosapent ethyl) — Recordati Industria Chimica e Farmaceutica S.p.A.
EMA authorised Vazkepa (icosapent ethyl) for the treatment of dyslipidemias; the marketing authorization holder is Recordati Industria Chimi…
-
FDA approval · 2026-03-11FDA Approved: FENOFIBRIC ACID — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Fenofibric acid by Alembic Pharmaceuticals Limited.
-
FDA approval · 2026-01-21FDA Approved: FENOFIBRATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's fenofibrate under an Original Application (ANDA 210379). The approval permits the generic fe…
-
CLINICAL_TRIALS approval · 2025-10-28Clinical Trial Update: Compassionate Use of Evinacumab
Evinacumab (brand Evkeeza) has gained marketing approval for use in pediatric homozygous familial hypercholesterolemia, as well as indicatio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-10-01FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Fenofibrate submitted by Lupin Pharmaceuticals, Inc., indicating a regulatory change to this…
-
FDA approval · 2025-08-28FDA Approved: FENOFIBRATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for fenofibrate, authorizing continued marketing of fenofibrate for lipid-…
-
FDA approval · 2025-08-21FDA Approved: FENOFIBRATE — Supplemental Application (AvKARE)
FDA approved a supplemental application for Fenofibrate by AvKARE. This approval supports the generic product's marketing under an approved …
-
FDA approval · 2025-08-21FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for fenofibrate filed by Cipla USA Inc. under the ANDA 208709.
-
FDA approval · 2025-08-21FDA Approved: FENOFIBRATE — Supplemental Application (Creekwood Pharmaceuticals LLC)
FDA approved a supplemental application for fenofibrate submitted by Creekwood Pharmaceuticals LLC. The action represents an approved regula…
-
FDA approval · 2025-08-06FDA Approved: ICOSAPENT ETHYL — Original Application (Vitruvias Therapeutics, Inc.)
FDA approved the original application for ICOSAPENT ETHYL by Vitruvias Therapeutics, Inc., enabling a generic version of the triglyceride-lo…
-
FDA approval · 2025-06-06FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approves a supplemental application for fenofibric acid submitted by Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2025-05-22FDA Approved: FENOFIBRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for fenofibrate (generic) under ANDA 201748, authorizing the mar…
-
FDA approval · 2024-12-19FDA Approved: TRYNGOLZA — Original Application (Ionis Pharmaceuticals, Inc.)
FDA approves TRYNGOLZA (olesarsen sodium) from Ionis Pharmaceuticals as a new molecular entity for the treatment of severe hypertriglyceride…
-
FDA approval · 2024-11-20FDA Approved: ICOSAPENT ETHYL — Original Application (Qilu Pharmaceutical Co., Ltd.)
The FDA approved ICOSAPENT ETHYL from Qilu Pharmaceutical Co., Ltd. via an original application (ANDA218899).
-
FDA approval · 2024-11-13FDA Approved: FENOFIBRATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's fenofibrate as an Original Application generic (ANDA 210248). This marks the approval of a g…
-
FDA approval · 2024-08-22FDA Approved: FENOFIBRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for fenofibrate submitted by Aurobindo Pharma Limited, relating to a generic fenofibrate product.
-
FDA approval · 2024-07-30FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Fenofibrate.
-
FDA approval · 2024-05-17FDA Approved: GEMFIBROZIL — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Gemfibrozil submitted by Chartwell RX, LLC.
-
FDA approval · 2024-02-16FDA Approved: ICOSAPENT ETHYL — Original Application (Northstar Rx LLC)
FDA approved the original application for icospent ethyl (ICOSAPENT ETHYL) from Northstar Rx LLC, a generic version of the prescription ther…
-
FDA approval · 2024-02-08FDA Approved: FENOFIBRIC ACID — Original Application (Macleods Pharmaceuticals Limited)
FDA approved an original application for fenofibric acid (generic) manufactured by Macleods Pharmaceuticals Limited.
-
FDA approval · 2024-02-01FDA Approved: GEMFIBROZIL — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for gemfibrozil by Chartwell RX, LLC.
-
FDA approval · 2024-01-31FDA Approved: FENOFIBRATE — Original Application (Chartwell RX, LLC.)
FDA approved fenofibrate (generic) under Original Application ANDA211407 for Chartwell RX, LLC. This marks the approval of a first generic v…
-
FDA approval · 2023-09-20FDA Approved: FENOFIBRIC ACID — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for fenofibric acid from Aurobindo Pharma Limited, updating the product’s labeling as part of the su…
-
FDA approval · 2023-09-07FDA Approved: FENOFIBRATE — Original Application (Creekwood Pharmaceuticals LLC)
The FDA approved Creekwood Pharmaceuticals LLC's original ANDA for a generic fenofibrate product.